Abbvie Inc
Change company Symbol lookup
Select an option...
ABBV Abbvie Inc
CHHL China Holdings Inc
DARE Dare Bioscience Inc
HEXEY Hellenic Exchanges Athens Stock Exchange SA
CLWA Fuzebox Software Corp
NGHC National General Holdings Corp
IVR Invesco Mortgage Capital Inc
CXP Columbia Property Trust Inc
TYTMF Tokyo Tatemono Co Ltd
ARPTF Airport City Ltd
Go

Health Care : Biotechnology | Large Cap Value
Company profile

AbbVie Inc. (AbbVie) is a research-based biopharmaceutical company. The Company is engaged in the discovery, development, manufacture and sale of a range of pharmaceutical products. Its products are focused on treating conditions, such as chronic autoimmune diseases in rheumatology, gastroenterology and dermatology; oncology, including blood cancers; virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV); neurological disorders, such as Parkinson's disease and multiple sclerosis; metabolic diseases, including thyroid disease and complications associated with cystic fibrosis, and other serious health conditions. It offers products in various categories, including HUMIRA (adalimumab), Oncology products, Virology Products, Additional Virology products, Metabolics/Hormones products, Endocrinology products and other products, which include Duopa and Duodopa (carbidopa and levodopa), Anesthesia products and ZINBRYTA (daclizumab).

Closing Price
$94.05
Day's Change
-1.30 (-1.36%)
Bid
--
Ask
--
B/A Size
--
Day's High
95.30
Day's Low
93.77
Volume
(Average)
Volume:
11,175,783

10-day average volume:
11,473,582
11,175,783
  • Prev Close
    95.35
  • Today's Open
    95.23
  • Day's Range
    93.77-95.30
  • Avg Vol (10-day)
    11.5M
  • Last (time)
    6:30p ET 02/14/20
  • Last (size)
    343
  • 52-Wk Range
    62.66 - 97.86
    LowHigh
  • (08/15/19 - 02/12/20)
    3.89%
  • 27.2%
  • Market Cap
    139.1B
  • Shares Outstanding
    1.5B
  • 2.23
  • 42.11x
  • $4.72/5.02%
  • Ex-dividend
    01/14/20
  • 1.0
  • 74.40
  • (% of float 01/31/20)
    5.06

Latest News

February 11, 2020
8:40 am ET
PR Newswire
8:00 am ET
PR Newswire
February 10, 2020
7:14 am ET
MarketWatch
February 07, 2020
9:31 am ET
PR Newswire
9:05 am ET
Zacks
8:10 am ET
MarketWatch
7:48 am ET
MarketWatch
7:48 am ET
MarketWatch
7:47 am ET
MarketWatch
7:47 am ET
MarketWatch
7:46 am ET
MarketWatch
7:45 am ET
MarketWatch
7:45 am ET
MarketWatch
February 05, 2020
8:45 am ET
PR Newswire
6:00 am ET
PR Newswire
February 03, 2020
9:31 am ET
PR Newswire
January 28, 2020
8:30 am ET
Globe Newswire
January 27, 2020
9:41 am ET
MarketWatch
8:18 am ET
PR Newswire
1:15 am ET
PR Newswire
January 25, 2020
4:41 pm ET
MarketWatch
January 22, 2020
6:00 am ET
PR Newswire
January 20, 2020
7:01 am ET
BusinessWire
January 18, 2020
9:51 am ET
MarketWatch
January 15, 2020
5:47 am ET
BusinessWire
January 14, 2020
8:45 am ET
PR Newswire
January 13, 2020
8:00 am ET
PR Newswire
January 08, 2020
3:38 pm ET
MarketWatch
8:00 am ET
PR Newswire
6:00 am ET
PR Newswire
January 03, 2020
8:00 am ET
PR Newswire
December 20, 2019
8:45 am ET
PR Newswire
6:00 am ET
PR Newswire
December 16, 2019
5:57 am ET
Globe Newswire
December 11, 2019
8:17 am ET
PR Newswire
Go to all current & historical news

Earnings Calendar and Events Data provided by |Terms of Use| © 2020 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2020. All rights reserved.